Impact of tricuspid repair on surgical death in patients undergoing mitral valve surgery due to rheumatic disease
| العنوان: | Impact of tricuspid repair on surgical death in patients undergoing mitral valve surgery due to rheumatic disease |
|---|---|
| المؤلفون: | L M Damasceno, P F Soares, J B Lopes, Luiz Carlos Santana Passos, Teresinha Cícera Teodora Viana, D N V Da Silva, Clara Salles Figueiredo, Jorge Santos, R.M Vieira De Melo, Andrea Barros Tolentino, G P Santana, Daniel Camara Azevedo, M L N De Paula |
| المصدر: | European Heart Journal. 42 |
| بيانات النشر: | Oxford University Press (OUP), 2021. |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | medicine.medical_specialty, business.industry, cardiovascular system, medicine, Rheumatic disease, In patient, Cardiology and Cardiovascular Medicine, business, Mitral valve surgery, Surgery |
| الوصف: | Introduction Observational studies differ on the impact of performing tricuspid repair on surgical mortality. Some studies demonstrate increased surgical mortality related to right ventricular failure and circulatory shock, while there are other studies that evidence improvement in quality of life and signs of right heart failure in the long time. Objective To evaluate the impact on surgical mortality of concomitant tricuspid annuloplasty in patients undergoing cardiac surgery for rheumatic mitral valve disease, who have moderate to severe tricuspid regurgitation. Methods This is a prospective cohort from January 1, 2017 to December 30, 2020. All patients over 18 years of age who underwent cardiac surgery to correct rheumatic mitral valve disease with moderate to significant tricuspid regurgitation were included. The primary outcome was 30-days mortality. Results 165 patients were included, 98 (59.4%) underwent tricuspid valve annuloplasty. The mean age was 46, 5 (±12) years, the median of Euroscore II was 2,33%. The 30-days mortality was 17 (10.3%) and there was no difference between the groups submitted or not to tricuspid repair: 12 (12.2%) versus 5 (7.5%); p=0.44, respectively. In the multivariate analysis involving seven variables with a potential prediction of death in 30 days, tricuspid repair had no association with death, RR 2,4 (0,5 – 8,3); p=0.27. Conclusion In patients with rheumatic heart disease undergoing cardiac surgery for rheumatic mitral valve disease, perform tricuspid annuloplasty in individuals who had moderate to severe tricuspid insufficiency was not associated with increased surgical mortality. Funding Acknowledgement Type of funding sources: None. |
| تدمد: | 1522-9645 0195-668X |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::57764b58029e57997d5d11a83be393c4 https://doi.org/10.1093/eurheartj/ehab724.2258 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi...........57764b58029e57997d5d11a83be393c4 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15229645 0195668X |
|---|